Pneumococcal Vaccine Extended to High-Risk Children, Teens

[ad_1]

FDA approves expanded indication for individuals aged 2-17 years with chronic medical conditions.
Medscape Medical News

[ad_2]

Source link : https://www.medscape.com/viewarticle/vaccine-protection-extended-high-risk-children-and-teens-2026a1000kug?src=rss

Author :

Publish date : 2026-06-19 15:34:00

Copyright for syndicated content belongs to the linked Source.

Exit mobile version